MedTrace Logo

An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus

NCT00432354 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2007-03-20

No results posted yet for this study

Summary

The aim of this study is to to determine whether atorvastatin 40mg per day is effective in the treatment of SLE.

Conditions

Interventions

DRUG

atorvastatin

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Buddhist Tzu Chi General Hospital

    lead OTHER

Principal Investigators

  • Ning-Sheng Lai, MD., Ph.D. · Vice President of Buddhist Dalin Chi Tzu General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Completion
2009-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00432354 on ClinicalTrials.gov